$2.66
-0.12-4.32%
At close: Aug 12, 5:00 PM EST
$2.78
0.124.51%
After Hours: 9:26 AM EST
Lantern Pharma Inc (LTRN) Stock Price, Quote, News & History
LTRNNASDAQ
Earnings: Q2 2026 earnings tomorrow on Thu Aug 13th after the market close
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lantern Pharma (LTRN) stock?
You can purchase shares of Lantern Pharma (NASDAQ:LTRN) through any online brokerage.
Who are Lantern Pharma (LTRN) competitors?
Other companies in Lantern Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Lantern Pharma (LTRN) stock?
Lantern Pharma has a consensus price target of $25.00.
What is the current price for Lantern Pharma (LTRN)?
The stock price for Lantern Pharma (NASDAQ: LTRN) is $2.78 last updated August 12, 2026 at 9:26 AM EDT.
Does Lantern Pharma (LTRN) pay a dividend?
There are no upcoming dividends for Lantern Pharma.
When is Lantern Pharma (NASDAQ:LTRN) reporting earnings?
Lantern Pharma does not have any upcoming earnings scheduled.
Is Lantern Pharma (LTRN) going to split?
There is no upcoming split for Lantern Pharma.
What sector and industry does Lantern Pharma (LTRN) operate in?
Lantern Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
